Advanced Medical Isotope Research and Development Expenses 2013-2024 | RDGL

Advanced Medical Isotope research and development expenses from 2013 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Advanced Medical Isotope Annual Research and Development Expenses
(Millions of US $)
2023 $1
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $
2012 $
Advanced Medical Isotope Quarterly Research and Development Expenses
(Millions of US $)
2024-03-31 $0
2023-12-31 $0
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
2022-09-30 $0
2022-06-30 $0
2022-03-31 $0
2021-12-31 $0
2021-09-30 $0
2021-06-30 $0
2021-03-31 $0
2020-12-31 $0
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2019-03-31 $0
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31 $0
2012-09-30
2012-06-30
2012-03-31
Sector Industry Market Cap Revenue
Finance Finance - SBIC & Commercial $0.072B $0.000B
Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington.
Stock Name Country Market Cap PE Ratio
Ares Capital (ARCC) United States $13.255B 9.03
Blackstone Secured Lending Fund (BXSL) United States $6.056B 8.20
FS KKR Capital (FSK) United States $5.741B 6.70
Main Street Capital (MAIN) United States $4.200B 11.48
Hercules Capital (HTGC) United States $3.201B 9.36
Golub Capital BDC (GBDC) United States $2.842B 8.50
Morgan Stanley Direct Lending Fund (MSDL) United States $2.070B 8.67
Goldman Sachs BDC (GSBD) United States $1.726B 6.66
New Mountain Finance (NMFC) United States $1.339B 8.13
Kayne Anderson BDC (KBDC) $1.138B 0.00
Bain Capital Specialty Finance (BCSF) United States $1.084B 7.56
BARINGS BDC, INC (BBDC) United States $1.065B 8.31
Nuveen Churchill Direct Lending (NCDL) United States $0.975B 0.00
BLACKROCK TCP CAPITAL CORP (TCPC) United States $0.948B 5.96
Carlyle Secured Lending (CGBD) United States $0.910B 8.37
SLR Investment (SLRC) United States $0.897B 9.56
Amalgamated Financial (AMAL) United States $0.772B 8.34
Trinity Capital (TRIN) United States $0.738B 6.81
Crescent Capital BDC (CCAP) United States $0.672B 7.59
CION Investment (CION) United States $0.670B 6.32
Fidus Investment (FDUS) United States $0.631B 7.87
Palmer Square Capital BDC (PSBD) United States $0.535B 0.00
Gladstone Investment (GAIN) United States $0.515B 14.17
PennantPark Investment (PNNT) United States $0.489B 7.13
Gladstone Capital (GLAD) United States $0.487B 11.37
Runway Growth Finance (RWAY) United States $0.472B 6.18
Horizon Technology Finance (HRZN) United States $0.406B 6.11
TriplePoint Venture Growth BDC (TPVG) United States $0.355B 4.81
Stellus Capital Investment (SCM) United States $0.335B 7.15
Saratoga Investment Corp (SAR) United States $0.325B 5.78
WhiteHorse Finance (WHF) United States $0.299B 6.95
Medallion Financial (MFIN) United States $0.194B 3.92
Oxford Square Capital (OXSQ) United States $0.185B 6.44
OFS Capital (OFS) United States $0.131B 6.32
PhenixFIN (PFX) United States $0.091B 17.45
Silver Spike Investment (SSIC) United States $0.071B 13.51
Logan Ridge Finance (LRFC) United States $0.060B 16.11
Investcorp Credit Management BDC (ICMB) United States $0.046B 5.76
Rand Capital (RAND) United States $0.000B 13.59